10h
Hosted on MSNRenault reveals future van line-upRenault has pulled the wraps off its new generation of electric vans, due to arrive in 2026 and reviving some iconic names ...
Glucotrack (GCTK) announced the successful completion of its first in human clinical study, marking a significant milestone in continuous ...
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
The Buildings and Grounds Committee of the Dougherty County Board of Education approved a bid Tuesday morning for the ...
Expanding Erasmus Shipinvest Group has established a new division for its growing container ship and multipurpose ships. The fresh branch called Erasmus Container Lines was announced as the company ...
The use of a continuous glucose monitor during pregnancy may be more cost-effective than self-monitoring blood glucose for ...
This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?
Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in ...
Researchers from the University of Virginia Center for Diabetes Technology have found that continuous glucose monitor data can predict if someone is at risk of developing eye, kidney and nerve ...
Research indicates that some individuals can achieve normal blood glucose levels on a keto diet, allowing them to reduce or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results